We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Teck Resources
TECK
$32.4B
| $443K | ﹤0.01% |
10,513
-8,769
| -45% | -$377K |
|
2227
Teucrium Sugar Fund
CANE
$53.9M
| $442K | ﹤0.01% |
+34,639
| New | +$461K |
|
|
IMGN
2228
DELISTED
Immunogen Inc
IMGN
| $442K | ﹤0.01% |
23,433
-27,968
| -54% | -$330K |
|
2229
AMN Healthcare
AMN
$1.34B
| $441K | ﹤0.01% |
4,042
+93
| +2% | +$8.82K |
|
2230
Mettler-Toledo International
MTD
$28.8B
| $441K | ﹤0.01% |
336
+135
| +67% | +$190K |
|
2231
Encompass Health
EHC
$12.3B
| $440K | ﹤0.01% |
6,504
+31
| +0.5% | +$1.94K |
|
2232
Dropbox
DBX
$7.31B
| $439K | ﹤0.01% |
16,442
-245
| -1% | -$5.58K |
|
2233
SSR Mining
SSRM
$6.49B
| $439K | ﹤0.01% |
30,941
+888
| +3% | +$13.4K |
|
2234
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $439K | ﹤0.01% |
8,504
-5,410
| -39% | -$241K |
|
2235
Flowers Foods
FLO
$1.52B
| $438K | ﹤0.01% |
+17,616
| New | +$467K |
|
2236
Goldman Sachs Access Emerging Markets USD Bond ETF
GEMD
$37.6M
| $438K | ﹤0.01% |
10,910
-927
| -8% | -$37K |
|
2237
Targa Resources
TRGP
$57.6B
| $438K | ﹤0.01% |
5,753
+370
| +7% | +$26.8K |
|
2238
AMERISAFE
AMSF
$517M
| $437K | ﹤0.01% |
8,201
-254
| -3% | -$13.5K |
|
2239
VanEck BDC Income ETF
BIZD
$1.71B
| $437K | ﹤0.01% |
28,439
-1,444
| -5% | -$21.1K |
|
|
SGI
2240
Somnigroup International
SGI
$13.5B
| $437K | ﹤0.01% |
10,902
-21
| -0.2% | -$790 |
|
2241
Essex Property Trust
ESS
$18.1B
| $436K | ﹤0.01% |
1,859
-98
| -5% | -$21.4K |
|
2242
Willis Towers Watson
WTW
$31B
| $436K | ﹤0.01% |
1,853
-15,793
| -89% | -$3.64M |
|
|
PFN
2243
PIMCO Income Strategy Fund II
PFN
$706M
| $432K | ﹤0.01% |
59,933
+5,633
| +10% | +$39.8K |
|
2244
Innovator Laddered Allocation Buffer ETF
BUFB
$331M
| $431K | ﹤0.01% |
16,485
-2,037
| -11% | -$50.7K |
|
2245
MasTec
MTZ
$22.6B
| $431K | ﹤0.01% |
3,652
-591
| -14% | -$57.9K |
|
2246
Winnebago Industries
WGO
$915M
| $431K | ﹤0.01% |
6,456
+146
| +2% | +$8.71K |
|
2247
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $430K | ﹤0.01% |
4,532
+348
| +8% | +$33.1K |
|
2248
iShares Core Dividend ETF
DIVB
$1.8B
| $430K | ﹤0.01% |
11,246
+4
| +0% | +$149 |
|
|
PCN
2249
PIMCO Corporate & Income Strategy Fund
PCN
$891M
| $428K | ﹤0.01% |
32,669
+3,607
| +12% | +$46K |
|
2250
Invesco BulletShares 2027 Municipal Bond ETF
BSMR
$347M
| $426K | ﹤0.01% |
18,046
+3,736
| +26% | +$88.5K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.